Echocardiographic Findings as Markers of Subclinical Cardiac Dysfunction in Patients With Non-Alcoholic Fatty Liver Disease
Conditions: NAFLD Interventions: Device: Echocardiographic findings Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2023 Category: Research Source Type: clinical trials
Proliverenol Supplementation for Non-Alcoholic Fatty Liver Disease (NAFLD)
Conditions: Non-Alcoholic Fatty Liver Disease (NAFLD) Interventions: Drug: Proliverenol; Drug: Placebo caplets of Proliverenol Sponsors: Dexa Medica Group; PT Equilab International Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials
Dexamethasone/Pancreatic Clamp P & F
Conditions: Insulin Resistance; Prediabetic State; Non-Alcoholic Fatty Liver Disease; Overweight and Obesity Interventions: Drug: Insulin human; Drug: Octreotide Acetate; Drug: Glucagon; Drug: Human Growth Hormone; Drug: Dexamethasone Oral; Other: [6,6-2H2] D-glucose; Drug: 20% D-glucose (aq); Dietary Supplement: BOOST Plus; Device: Harvard Apparatus PHD ULTRA CP syringe pump; Device: Yellow Springs Instruments (YSI) 2500 Biochemistry Glucose/Lactate Analyzer; Other: Normal saline; Other: Human albumin Sponsors: Columbia University; Albert Einstein College of Medicine; National Institute of Diabetes and Digestive and Kidne...
Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials
Outcomes of Children After Hospitalization in Intensive Care Unit
Conditions: Renal Disease; Liver Diseases; Heart Diseases; Trauma Injury; Sepsis; Septic Shock; Pneumonia; Bronchiolitis Interventions: Other: neurocognitive tests Sponsors: St. Justine ' s Hospital; Canadian Institutes of Health Research (CIHR) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2023 Category: Research Source Type: clinical trials
Behavioral Lifestyle Intervention for Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Adults
Conditions: Metabolic Associated-dysfunction Steatotic Liver Disease (MASLD); Metabolic Associated-dysfunction Steatohepatitis (MASH) Interventions: Behavioral: Standard of care acceptance-based behavioral weight loss program; Behavioral: Occupational therapy dietary and lifestyle modifications Sponsors: Grand Valley State University Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 8, 2023 Category: Research Source Type: clinical trials
The Impact Of SGLT2 -I on Metabolic Dysfunction -Associated Steatotic Liver Disease In Patients With Type 2 Diabetes Mellitus
Conditions: Fatty Liver, Nonalcoholic Interventions: Drug: SGLT2 inhibitor Sponsors: Sohag University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2023 Category: Research Source Type: clinical trials
Kuwait Adult Diabetes Epidemiological Multidisciplinary (KADEM) Program
Conditions: Diabetes Mellitus Type 2, Diabetes Mellitus Type 1; NAFLD - Nonalcoholic Fatty Liver Disease; PreDiabetes Sponsors: Dasman Diabetes Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2023 Category: Research Source Type: clinical trials
The Gut, Liver And Metabolome in Human Immunodeficiency Virus and Non Alcoholic Fatty Liver Disease
Conditions: HIV; Non-Alcoholic Fatty Liver Disease; Metabolic-Associated Steatotic Liver Disease Interventions: Dietary Supplement: Prebiotic; Dietary Supplement: Probiotic Sponsors: Vanderbilt University Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2023 Category: Research Source Type: clinical trials
Depressive and Anxiety Disorders in Patients With Chronic Liver Diseases
Conditions: Depression, Anxiety Interventions: Diagnostic Test: The Hamilton Rating Scale for Anxiety; Diagnostic Test: The Beck Depression inventory; Diagnostic Test: Rand SF-36 Questionnaire Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2023 Category: Research Source Type: clinical trials
Effectiveness of Ultrasound in Liver Stiffness and Fat Quantification
Conditions: Liver Disease Chronic; Fibrosis, Liver; Liver Steatoses; Liver Fat; NAFLD; NASH With Fibrosis; Hepatitis Interventions: Diagnostic Test: Ultrasound based Elastography and fat quantification Sponsors: King ' s College Hospital NHS Trust; Samsung Medison Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2023 Category: Research Source Type: clinical trials
Dose Exploration Study of GSK4532990 in Participants With NASH or Suspected NASH
Conditions: Non-alcoholic Fatty Liver Disease Interventions: Drug: GSK4532990 Sponsors: GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2023 Category: Research Source Type: clinical trials
Observational and Prospective Study of Hepatic Steatosis and Related Risk Factors Using Ultrasound and Artificial Intelligence
Conditions: Steatotic Liver Disease; Artificial Intelligence; Ultrasound Sponsors: University of Bari; Eurisko Technology srl; Centro Radiologico Lucano Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials
Ultrasound Assessment of Sarcopenia in Patients With Chronic Liver Disease: the SARCOLIVER Study
Conditions: Liver Cirrhosis; Non-Alcoholic Fatty Liver Disease; Hepatocellular Carcinoma Interventions: Diagnostic Test: Handgrip strength test; Diagnostic Test: total body Dual Energy X-Ray Absorptiometry (DXA); Diagnostic Test: Muscle ultrasound Sponsors: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials
The Effect of Soy Isoflavones on Non-alcoholic Fatty Liver Disease and the Level of FGF-21 and Fetuin A
Conditions: NAFLD Interventions: Dietary Supplement: Soy isoflavone; Other: Placebo Sponsors: Ahvaz Jundishapur University of Medical Sciences Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials
Study of Clinical Features of Patients With Autoimmune Liver Disease Complicated With Covid-19 and the Immune Mechanism Affecting Prognosis
Conditions: Autoimmune Liver Disease, COVID-19 Interventions: Other: Different types of disease Sponsors: The Second Affiliated Hospital of Chongqing Medical University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2023 Category: Research Source Type: clinical trials
